In 1991-1998 year period, 50 nasopharyngeal cancer (NPC) patients (divided into 2 groups: case group and control group) were treated by phylamin. Good results were manifested, patient resistance capacity enhanced in the course of irradiation, reduced the prosibility of development of communicable disease by 2.5 times. Patients had weight gain, maintaining their working productivity and selt service capacity. 3 years survival duration had got 77% in case group, while 40% in control group.
Nasopharyngeal Neoplasms ; Therapeutics ; Weight Gain ; Control Groups